45 results
DRS
EX-10.56
VIR
Vir Biotechnology Inc
23 Jun 20
Draft registration statement
12:00am
” means the compounding, filling, producing and primary packaging of Drug Product in accordance with the applicable Specifications.
1.43 “[***]” means … hereunder (as applicable), including, manufacturing, processing, packaging, labeling, testing, stability testing, process qualification, cell culture
S-1
EX-10.33
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
, packaging, labeling, quality assurance testing, release of an Enhanced Product or Enhanced Product candidate, whether for Development or Commercialization … , or that, if required, the license will issue.
14.3.Marking. Company agrees that packaging containing Enhanced Products manufactured and sold under the terms
DRS/A
EX-10.33
VIR
Vir Biotechnology Inc
7 Aug 19
Draft registration statement (amended)
12:00am
, packaging, labeling, quality assurance testing, release of an Enhanced Product or Enhanced Product candidate, whether for Development or Commercialization … , or that, if required, the license will issue.
14.3.Marking. Company agrees that packaging containing Enhanced Products manufactured and sold under the terms
DRS/A
EX-10.17
c66bb dx1uk1vk0h
7 Aug 19
Draft registration statement (amended)
12:00am
S-1
EX-10.17
p7d tfcyac
3 Sep 19
IPO registration
4:40pm
DRS
EX-10.53
80bnyvnpz e3u6qpdy
23 Jun 20
Draft registration statement
12:00am
S-1
EX-10.21
m7t631fk0p0gd 3pbf4u
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.16
c3uram
3 Sep 19
IPO registration
4:40pm
DRS
EX-10.55
on6j55khvk9cx tdsy
23 Jun 20
Draft registration statement
12:00am
DRS/A
EX-10.16
59l97fbp1a9ls
7 Aug 19
Draft registration statement (amended)
12:00am
S-3ASR
EX-1.2
9wwz399urchc7emwj5v
3 Nov 23
Automatic shelf registration
4:33pm
DRS/A
EX-10.35
gx9b6c1i
7 Aug 19
Draft registration statement (amended)
12:00am